Elisabeth G. Celius retweetledi
14.3 % of people with MS have paramagnetic rim lesions (PRLs) (dark rim on SWI sequence) which correlate with higher disability [data from Norway] pmc.ncbi.nlm.nih.gov/articles/PMC12…
English
Elisabeth G. Celius
435 posts
Elisabeth G. Celius
@CeliusElisabeth
Professor in neurology with special interest in multiple sclerosis.
Katılım Nisan 2013
356 Takip Edilen265 Takipçiler
Elisabeth G. Celius retweetledi
🚨 New @MAGNIMS study (19 sites): Distinguishing MS from MOGAD is challenging. Integrating #AI with clinical & #MRI data improves diagnostic accuracy in demyelinating diseases. #MSResearch #AIinMedicine #Neuroimaging neurology.org/doi/10.1212/WN…
English
Elisabeth G. Celius retweetledi
MAPLE is out-an important study of pharmacovigilance data by @merck_de on the Safety of drug exposure of cladribine 6 months before or during🤰 . Only one MCA(1,1%) since data collection started in 2017. Very happy to see this paper online🥳. pubmed.ncbi.nlm.nih.gov/40587835/
English
Elisabeth G. Celius retweetledi
Skattebøl et al. report that deep learning predicts brain age in MS more accurately than traditional ML and resists scanner variability. Please read at: buff.ly/CqHOEG6 #MS
English
Brain age in multiple sclerosis: a study with deep learning and traditional machine learning academic.oup.com/braincomms/art…
English
Elisabeth G. Celius retweetledi
Original Article: Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis (HERCULES phase 3 trial) nej.md/4l3N9e5
#AANAM | @AANmember
English
Elisabeth G. Celius retweetledi
Thank you @ECTRIMS and @ACTRIMS for your support and retweets!
If anyone else cld repost this - in hopes of reaching as many women MS researchers as possible - that wld be v appreciated.
@MSCanOfficial
ECTRIMS@ECTRIMS
🏆 The 2025 @RachelHorne19 Prize (US$40,000) honours a rising star female scientist in #MS research. Are you an early to mid-career researcher making an impact in MS research? Apply now! 🔗 bit.ly/3DaR47N #RachelHornePrize #WomenInMSMatter #IWD
English
Reduced childbirth rates in multiple sclerosis from the prodromal phase: Evidence from a population-based cohort st… pubmed.ncbi.nlm.nih.gov/39957514/
English
Elisabeth G. Celius retweetledi
The "Brain Health – Time Matters" report highlights advancements in #MS, #NMOSD & #MOGAD, stressing early diagnosis & treatment. It calls for policy changes to support patients and includes rare neuroimmune conditions to improve global care. msbrainhealth.org
English
The influence of menopause on multiple sclerosis - Simonsen - European Journal of Neurology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/en…
English
Elisabeth G. Celius retweetledi
The new ‘Brain health – time matters’ is now available to access. MSIF and its member organisations are proud to be involved with this important research, exploring the latest advancements and needs in MS, NMOSD, and MOGAD. Learn more here: msintfederation.org/3YCd6I8
English
Viktig debatt på riktige premisser! e-avis.aftenposten.no/shared/article…
Svenska
English
So pleased to announce Prof @KerstinHellwig is the 2024 winner of the Rachel Horne Prize for Women's Research in MS!
Dr Hellwig, neurologist/clinician at @ruhrunibochum in Germany, is being honoured for her pioneering work into MS & family planning.
Prize to be given at @ECTRIMS
English
Elisabeth G. Celius retweetledi
New report Brain health – time matters in #MS, #NMOSD & #MOGAD launches 19 Sept 2024, 13:30–15:00 CET at @ECTRIMS, in #Copenhagen & virtually. Join @GavinGiovannoni, Helmut Butzkeuven, @AnneHelme, @NerdyNeuroMD & @TheSumairaFDN to learn about policy change. #BrainHealthTM #OHPF
English
COVID-19 and multiple sclerosis: challenges and lessons for patient care - The Lancet Regional Health – Europe thelancet.com/journals/lanep…
English
Elisabeth G. Celius retweetledi
Our 3rd clinical series for 2024 is live: Multiple Sclerosis 2024.
It covers advances in MS across 4 key areas: epidemiological trends, MRI for disease management, fluid biomarkers, & the impact of SARS-CoV-2 on MS.
Explore these insights here👇
thelancet.com/series/multipl…
English
Elisabeth G. Celius retweetledi
Letter from @PStridhKI @MultipleMS_EU @karolinskainst: Genotype differences might need time to manifest clinically in #MultipleSclerosis, and lack of associations likely reflects insufficient power.
🔽
journals.sagepub.com/doi/10.1177/13…
MSJ@MSJ_Research
A genetic variant potentially related to #MultipleSclerosis severity (rs10191329) did not associate with EDSS-derived outcomes, suggesting complex genetics mediating long-term outcomes. @MSBase_Registry study from @vjokubaitis @STMneurosci @MonashUni ▶️ journals.sagepub.com/doi/full/10.11…
English
@KerstinHellwig Thank you all for very important information!
English
Exposure to anti-cd 20 mabs shortly before or early during pregnancy or lactation does not alter B cell counts in newborns.Are we ready for a label change?
🤱🤰thank you- coauthors and of course a special thanks to all women and their babies. ncbi.nlm.nih.gov/pmc/articles/P…
English
Great collaboration! Well done @RosaCortese5
Rosa Cortese@RosaCortese5
Our new collaborative work is finally out in Annals of Neurology! Huge thanks to @ECTRIMS @MAGNIMS for this incredible opportunity and to all our collaborators for their amazing contributions. 🌟 #MOGAD #NMOSD #MS onlinelibrary.wiley.com/doi/10.1002/an…
English